A study published in the Journal of Bone and Mineral Research by Tel Aviv University and Hebrew University researchers explores another promising new medical application for Cannabidiol. According to the research, the administration of the non-psychotropic component cannabinoid cannabidiol (CBD)
Endexx Announces Global CBD License & Distribution Deal With Cannabis Infusion Brand the Mad Hatter Coffee & Tea Co.
Endexx has announced a license and distribution deal with The Mad Hatter Coffee & Tea Co., to deliver Cannabidiol (CBD) rich beverages that will be available globally. The Mad Hatter Coffee & Tea Co. has led the niche market of cannabis-infused
Endexx Initiates Adaptive Clinical Study With Proprietary CBD Capsule Formulation to Address Neuropathic Pain
Endexx Initiates Adaptive Clinical Study With Proprietary CBD Capsule Formulation to Address Neuropathic Pain Endexx Corporation (OTC PINK: EDXC), a provider of innovative hemp derived phyto-nutrients and nutritional products, has announced the launch of a doctor supervised, adaptive clinical study to